Cocrystal Pharma logo

Cocrystal Pharma Share Price (NASDAQ: COCP)

$1.54

-0.03

(-1.91%)

Last updated on

Check the interactive Cocrystal Pharma Stock chart to analyse performance

Cocrystal Pharma stock performance

as on August 30, 2025 at 1:27 am IST

  • Today's Low:$1.52
    Today's High:$1.56

    Day's Volatility :2.56%

  • 52 Weeks Low:$1.12
    52 Weeks High:$3.26

    52 Weeks Volatility :65.64%

Cocrystal Pharma Stock Returns

PeriodCocrystal Pharma IncIndex (Russel 2000)
3 Months
-7.88%
0.0%
6 Months
-15.08%
0.0%
1 Year
-11.58%
0.0%
3 Years
-66.22%
-4.7%

Cocrystal Pharma Inc Key Stats

Check Cocrystal Pharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.57
Open
$1.56
Today's High
$1.56
Today's Low
$1.52
Market Capitalization
$16.1M
Today's Volume
$45.0K
52 Week High
$3.26
52 Week Low
$1.12
Revenue TTM
$510.0K
EBITDA
$-12.6M
Earnings Per Share (EPS)
$-1.24
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-110.56%

Stock Returns calculator for Cocrystal Pharma Stock including INR - Dollar returns

The Cocrystal Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cocrystal Pharma investment value today

Current value as on today

₹94,819

Returns

₹5,181

(-5.18%)

Returns from Cocrystal Pharma Stock

₹10,465 (-10.47%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cocrystal Pharma Stock

33%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cocrystal Pharma Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cocrystal Pharma Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    2.64%

  • Renaissance Technologies Corp

    1.23%

  • BlackRock Inc

    0.72%

  • Geode Capital Management, LLC

    0.72%

  • Neuberger Berman Group LLC

    0.58%

  • Susquehanna International Group, LLP

    0.33%

Analyst Recommendation on Cocrystal Pharma Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Cocrystal Pharma(by analysts ranked 0 to 5 stars)

Cocrystal Pharma Share Price Target

What analysts predicted

Upside of 419.48%

Target:

$8.00

Current:

$1.54

Cocrystal Pharma share price target is $8.00, a slight Upside of 419.48% compared to current price of $1.54 as per analysts' prediction.

Cocrystal Pharma Stock Insights

  • Price Movement

    In the last 1 month, COCP stock has moved down by -9.0%
  • COCP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 85.5%
  • COCP vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 182.1%
  • Price to Sales

    ForCOCP every $1 of sales, investors are willing to pay $253.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Cocrystal Pharma Technicals Summary

Sell

Neutral

Buy

Cocrystal Pharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cocrystal Pharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cocrystal Pharma Inc logo
-17.84%
-15.08%
-11.58%
-66.22%
-87.31%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Cocrystal Pharma Inc

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. It employs structure-based technologies to create antiviral drugs including influenza virus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as norovirus, respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, a HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was founded in 2006 and is based in Bothell, Washington.
Organization
Cocrystal Pharma
Employees
11
CEO
Dr. Sam Lee Ph.D.
Industry
Health Technology

Key Management of Cocrystal Pharma Inc

NameTitle
Dr. Roger D. Kornberg Ph.D.
Co-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board
Dr. Sam Lee Ph.D.
Co-Founder, Co-CEO & President
Mr. James J. Martin CPA, M.B.A.
Co-CEO, CFO & Corporate Secretary

Important FAQs about investing in COCP Stock from India :

What is Cocrystal Pharma share price today?

Cocrystal Pharma share price today is $1.54 as on at the close of the market. Cocrystal Pharma share today touched a day high of $1.56 and a low of $1.52.

What is the 52 week high and 52 week low for Cocrystal Pharma share?

Cocrystal Pharma share touched a 52 week high of $3.26 and a 52 week low of $1.12. Cocrystal Pharma stock price today i.e. is closed at $1.54, lower by 52.76% versus the 52 week high.

How to invest in Cocrystal Pharma Stock (COCP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cocrystal Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cocrystal Pharma Shares that will get you 0.9740 shares as per Cocrystal Pharma share price of $1.54 per share as on August 30, 2025 at 1:27 am IST.

What is the minimum amount required to buy Cocrystal Pharma Stock (COCP) from India?

Indian investors can start investing in Cocrystal Pharma (COCP) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cocrystal Pharma stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cocrystal Pharma share’s latest price of $1.54 as on August 30, 2025 at 1:27 am IST, you will get 6.4935 shares of Cocrystal Pharma. Learn more about fractional shares .

What are the returns that Cocrystal Pharma has given to Indian investors in the last 5 years?

Cocrystal Pharma stock has given -87.31% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?